Moshe Benhamou
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis.
Journal: Journal of neuroimmunology
Published: April 17, 2022
Regenerative Effect of Adipose Derived Mesenchymal Stem Cells on Ganglion Cells in the Hypoxic Organotypic Retina Culture.
Journal: International journal of stem cells
Published: March 15, 2022
Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: May 31, 2021
Increased Expression of Ephrins on Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis Affects Oligodendrocyte Differentiation.
Journal: International journal of molecular sciences
Published: January 28, 2021
Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple Sclerosis.
Journal: CNS drugs
Published: November 13, 2019
Reduced levels of Coco in sera of multiple sclerosis patients: A potential role in neuro-regeneration failure.
Journal: Journal of neuroimmunology
Published: October 22, 2018
Adipose-Derived Mesenchymal Stem Cells Migrate and Rescue RPE in the Setting of Oxidative Stress.
Journal: Stem cells international
Published: May 24, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026